![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Trapp, Elisabeth K.; Fasching, Peter A.; Fehm, Tanja; Schneeweiss, Andreas; Mueller, Volkmar; Harbeck, Nadia; Lorenz, Ralf; Schumacher, Claudia; Heinrich, Georg; Schochter, Fabienne; de Gregorio, Amelie; Tzschaschel, Marie; Rack, Brigitte; Janni, Wolfgang und Friedl, Thomas W. P.
(2022):
Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial.
In: Cancers, Bd. 14, Nr. 16, 3949
Trapp, Elisabeth; Janni, Wolfgang; Schindlbeck, Christian; Jueckstock, Julia; Andergassen, Ulrich; de Gregorio, Amelie; Alunni-Fabbroni, Marianna; Tzschaschel, Marie; Polasik, Arkadius; Koch, Julian G.; Friedl, Thomas W. P.; Fasching, Peter A.; Haeberle, Lothar; Fehm, Tanja; Schneeweiss, Andreas; Beckmann, Matthias W.; Pantel, Klaus; Müller, Volkmar; Rack, Brigitte und Scholz, Christoph
(2019):
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis.
In: Jnci-Journal of the National Cancer Institute, Bd. 111, Nr. 4, djy152: S. 380-387
Alunni-Fabbroni, Marianna; Majunke, Leonie; Trapp, Elisabeth K.; Tzschaschel, Marie; Mahner, Sven; Fasching, Peter A.; Fehm, Tanja; Schneeweiss, Andreas; Beck, Thomas; Lorenz, Ralf; Friedl, Thomas W. P.; Janni, Wolfgang und Rack, Brigitte
(2018):
Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
In: BMC Cancer
18:141
[PDF, 1MB]
Schochter, Fabienne; Rack, Brigitte; Tzschaschel, Marie; Polasik, Arkadius; Andergassen, Ulrich; Trapp, Elisabeth; Alunni-Fabbroni, Marianna; Schneeweiss, Andreas; Müller, Volkmar; Pantel, Klaus; Gade, Jörg; Lorenz, Ralf; Rezai, Mahdi; Tesch, Hans; Soeling, Ulrike; Fehm, Tanja; Mahner, Sven; Schindlbeck, Christian; Lichtenegger, Werner; Beckmann, Matthias W.; Fasching, Peter A.; Janni, Wolfgang und Friedl, Thomas W. P.
(2018):
Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.
In: Oncology Research and Treatment, Bd. 41, Nr. 3: S. 93-98